![0138 ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years' anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapy]()
0138 ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years' anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapyM. Gnant; B. Mlineritsch; P. Dubsky; C. Menzel; W. Schippinger; D. Manfreda; S. Poestlberger; J. Thaler; M. Stierer; E. Kubista; F. Haslbauer; E. Melbinger; G. Luschin-Ebengreuth; P. Sevelda; V. Marth; H. Trapl; G. Steger; C. Tausch; F. Fitzal; R. Greil; R. Jakesz · 2009